Phosphorus-32-colloidal chromic phosphate: treatment of choice for malignant pericardial effusion.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2266403.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 68-yr-old male with agnogenic myeloid metaplasia was given phosphorus-32-colloidal chromic phosphate intrapericardially for the treatment of malignant pericardial effusion. Technetium-99m-sulfur colloid was used to verify catheter placement and to visualize distribution within the pericardium. Estimated dosimetry for this mode of therapy is presented, and it is suggested that pericardial administration of phosphorus-32-colloidal chromic phosphate is the treatment of choice for malignant pericardial effusion.
Medical subject headings
- Chromium Compounds
- Pericardial Effusion
- Phosphorus Radioisotopes